Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Key Highlights
- ➤Health Canada authorizes Moderna’s mFLUSIVA and mCOFLU for adults 50 and older
- ➤mFLUSIVA showed 26.6% relative efficacy versus standard-dose influenza vaccine
- ➤mCOFLU delivered non-inferior immune responses versus co-administered comparator vaccines
- ➤Canada becomes first country to authorize both Moderna seasonal respiratory vaccines
Expert Statements
Stéphane Bancel, Chief Executive Officer of Moderna
“Health Canada's authorizations of mFLUSIVA and mCOFLU today mark another important step in bringing the benefits of mRNA technology to seasonal respiratory vaccination. It's not every day that a company gets two product approvals on the same day.”
Stéphane Bancel, Chief Executive Officer of Moderna
“Influenza and COVID-19 continue to place a significant burden on public health, particularly among older adults. These milestones reflect our commitment to advancing innovative vaccine options that help protect Canadians and support more resilient health systems.”
CAMBRIDGE, MA / ACCESS Newswire / November 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that Health Canada has authorized mFLUSIVA(®) (Influenza mRNA vaccine; mRNA-1010) and mCOFLU(®) (Combined Influenza and COVID-19 mRNA vaccine; mRNA-1083) for adults 50 years of age and older. Canada is the first country in the world to authorize both Moderna's seasonal mRNA influenza vaccine and combination influenza and COVID-19 vaccine.
"Health Canada's authorizations of mFLUSIVA and mCOFLU today mark another important step in bringing the benefits of mRNA technology to seasonal respiratory vaccination. It's not every day that a company gets two product approvals on the same day," said Stéphane Bancel, Chief Executive Officer of Moderna. "Influenza and COVID-19 continue to place a significant burden on public health, particularly among older adults. These milestones reflect our commitment to advancing innovative vaccine options that help protect Canadians and support more resilient health systems."
Get started
Create a free account to read the full story.